Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wester

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Ophthalmology|February 13, 2024
ReplyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Journal of Pediatric Surgery|June 20, 2025
Systematic Review on Questionnaires Reporting Bowel Function and Health-related Quality of Life in Patients With Hirschsprung DiseaseA T Hoel, S Olsboe, J R Davidson, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2022
Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasisSilvana Leit, Jeremy R Greenwood, Sayan Mondal, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubilityA Guzman-Perez, R T Wester, M C Allen, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 12, 2022
Outcomes of Patients With Thyroid Eye Disease Partially Treated With TeprotumumabTiffany C Ho, Robi N Maamari, Andrea L Kossler, et al.
Physical Review Letters|April 26, 2018
Improved Limit on Neutrinoless Double-β Decay of ^{76}Ge from GERDA Phase IIM Agostini, A M Bakalyarov, M Balata, et al.
Science (New York, N.Y.)|September 7, 2019
Probing Majorana neutrinos with double-β decayM Agostini, A M Bakalyarov, M Balata, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Journal of Medicinal Chemistry|June 19, 1998
7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as novel inhibitors of human eosinophil phosphodiesteraseA J Duplantier, C J Andresen, J B Cheng, et al.
Ophthalmology|February 13, 2024
ReplyShreya A Shah, Linus Amarikwa, Connie M Sears, et al.
Journal of Pediatric Surgery|June 20, 2025
Systematic Review on Questionnaires Reporting Bowel Function and Health-related Quality of Life in Patients With Hirschsprung DiseaseA T Hoel, S Olsboe, J R Davidson, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2022
Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasisSilvana Leit, Jeremy R Greenwood, Sayan Mondal, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2001
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubilityA Guzman-Perez, R T Wester, M C Allen, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2023
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye DiseaseGeorge J Kahaly, Peter J Dolman, Jan Wolf, et al.
Ophthalmic Plastic and Reconstructive Surgery|September 12, 2022
Outcomes of Patients With Thyroid Eye Disease Partially Treated With TeprotumumabTiffany C Ho, Robi N Maamari, Andrea L Kossler, et al.
Physical Review Letters|April 26, 2018
Improved Limit on Neutrinoless Double-β Decay of ^{76}Ge from GERDA Phase IIM Agostini, A M Bakalyarov, M Balata, et al.
Science (New York, N.Y.)|September 7, 2019
Probing Majorana neutrinos with double-β decayM Agostini, A M Bakalyarov, M Balata, et al.
Pageof 12